Your browser doesn't support javascript.
loading
TACE plus PD-1 inhibitor (Camrelizumab) treatment for bridging to tumor resection in HCC: Case reports.
Xin, Haibei; Zhang, Cunzhen; Ding, Zhiwen; Zhang, Minfeng; Ding, Guanghui; Li, Nan.
Afiliação
  • Xin H; Department of Hepatic Surgery I (Ward I), The Third Affiliated Hospital of Naval Military Medical University, 700 Moyu Road, Jiading District, Shanghai 201805, China.
  • Zhang C; Department of Hepatic Surgery I (Ward I), The Third Affiliated Hospital of Naval Military Medical University, 700 Moyu Road, Jiading District, Shanghai 201805, China.
  • Ding Z; Department of Hepatic Surgery I (Ward I), The Third Affiliated Hospital of Naval Military Medical University, 700 Moyu Road, Jiading District, Shanghai 201805, China.
  • Zhang M; Department of Hepatic Surgery I (Ward I), The Third Affiliated Hospital of Naval Military Medical University, 700 Moyu Road, Jiading District, Shanghai 201805, China.
  • Ding G; Department of Hepatic Surgery I (Ward I), The Third Affiliated Hospital of Naval Military Medical University, 700 Moyu Road, Jiading District, Shanghai 201805, China.
  • Li N; Department of Hepatic Surgery I (Ward I), The Third Affiliated Hospital of Naval Military Medical University, 700 Moyu Road, Jiading District, Shanghai 201805, China. Electronic address: liparislisi@aliyun.com.
Clin Res Hepatol Gastroenterol ; 46(1): 101777, 2022 01.
Article em En | MEDLINE | ID: mdl-34333197
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Quimioembolização Terapêutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Clin Res Hepatol Gastroenterol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Quimioembolização Terapêutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Clin Res Hepatol Gastroenterol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China